✦ LIBER ✦

Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune response

✍ Scribed by M. TRAPERO-MARUGÁN; L. GARCÍA-BUEY; C. MUÑOZ; N. E. QUINTANA; J. A. MORENO-MONTEAGUDO; M. J. BORQUE; M. J. FERNÁNDEZ; F. R. SALVANÉS; J. MEDINA; R. MORENO-OTERO

Book ID: 108604593
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 192 KB
Volume: 24
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.02954.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin resistance is a major determinan

Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon α-2b plus ribavirin

✍ C.-J. CHU; S.-D. LEE; T.-H. HUNG; H.-C. LIN; S.-J. HWANG; F.-Y. LEE; R.-H. LU; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Pretreatment prediction of response to p

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis

✍ Masayuki Kurosaki; Naoya Sakamoto; Manabu Iwasaki; Minoru Sakamoto; Yoshiyuki Su 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 460 KB

Prediction of response to peginterferon-

Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b

✍ Yoshimasa Hashimoto; Hidenori Ochi; Hiromi Abe; Yasufumi Hayashida; Masataka Tsu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

## Abstract Variation at the IL‐28B locus was recently reported to be a significant predictive factor of viral response to pegylated‐interferon plus ribavirin combination therapy against chronic hepatitis C. Predictive factors for the effect of therapy, including IL‐28B polymorphism rs8099917 and v

Pretreatment prediction of virological r

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns

✍ Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Yen Hsieh; Ming-Lung Yu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

We read with great interest the article published in a recent issue of HEPATOLOGY. 1 Shirakawa et al. enrolled 120 patients with chronic hepatitis C (CHC) infected with genotype 1 hepatitis C virus (HCV-1) and high baseline viral loads (HVL), defined by HCV RNA levels Ն 10 5 international units (IU)

Virologic response rates of weight-based

Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C

✍ Fred Poordad; Eric Lawitz; Mitchell L. Shiffman; Tarek Hassanein; Andrew J. Muir 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 1 views

Muir is a consultant for, is on the speakers' bureau of, and received grants from Merck. He received grants from Valeant. He is also a consultant for and received grants from Zynogenetics. Dr. Poordad is a consultant for and received grants from Valeant. Dr. Shiffman advises and received grants from